A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.
Condition: Papillary Thyroid Cancer Intervention: Drug: Imatinib Oral Tablet Sponsors: AHS Cancer Control Alberta; Alberta Cancer Foundation Not yet recruiting
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου